Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications
Results of a phase II trial of short-course radiation and TASOX [trifluridine/tipiracil (TAS-102) plus oxaliplatin] chemotherapy in operable rectal cancer.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
The Evolving Role for Repeat Molecular Testing in Metastatic Colorectal Cancer.
Journal: Cancers
Published: January 10, 2026
NANETS Guidelines for the diagnosis and management of stage I-III rectal neuroendocrine tumors.
Journal: Endocrine-related cancer
Published: September 05, 2025
Phase Ib Study to Assess the Safety of Neoadjuvant Trifluridine/Tipiracil With Concurrent Radiation in Resectable Stage II/III Rectal Cancer: The FIERCE Study.
Journal: Clinical colorectal cancer
Published: August 25, 2025
Dual PET Imaging with [68Ga]Ga-DOTA-TOC and [18F]FDG to Localize Neuroendocrine Tumors of Unknown Origin.
Journal: Current oncology (Toronto, Ont.)
Published: July 23, 2025
Appropriate use of tissue sampling and somatostatin receptor PET imaging in the diagnosis of pancreatic neuroendocrine tumors: results of an International Delphi Consensus.
Journal: Surgical endoscopy
Published: February 03, 2025
Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO Guideline.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 16, 2024
Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial.
Journal: Journal for immunotherapy of cancer
Published: November 11, 2024
Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors.
Journal: Cancer research communications
Published: October 31, 2024
Management of Locally Advanced Rectal Cancer: ASCO Guideline Clinical Insights.
Journal: JCO oncology practice
Published: September 05, 2024
Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient.
Journal: JCO precision oncology
Published: August 23, 2024
Management of Locally Advanced Rectal Cancer: ASCO Guideline.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 08, 2024
Last Updated: 09/26/2026